GASTROESOPHAGEAL-JUNCTION CANCER (GEJ)

Clinical trials for GASTROESOPHAGEAL-JUNCTION CANCER (GEJ) explained in plain language.

Never miss a new study

Get alerted when new GASTROESOPHAGEAL-JUNCTION CANCER (GEJ) trials appear

Sign up with your email to follow new studies for GASTROESOPHAGEAL-JUNCTION CANCER (GEJ), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New cancer drug AB598 enters first human trials

Disease control Ongoing

This is the first human study testing the safety of an experimental drug called AB598 in people with advanced cancers. The trial will enroll 40 participants with various cancers including lung, stomach, bladder, and breast cancer to determine safe dosage levels and monitor side e…

Matched conditions: GASTROESOPHAGEAL-JUNCTION CANCER (GEJ)

Phase: PHASE1 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

GASTROESOPHAGEAL-JUNCTION CANCER (GEJ)

Get alerted when new GASTROESOPHAGEAL-JUNCTION CANCER (GEJ) trials appear

New cancer drug AB598 enters first human trials